Objective To investigate the pattern and trends of use of antipsychotics, antidepressants,
hypnotics and anxiolytics in Alzheimer's disease and other dementias and in patients treated …

Alzheimer's Disease (AD) exerts a significant worldwide impact. An estimated 44 million
individuals currently live with this Major Neurocognitive Disorder. There are about 6.2 million …

Objectives Antidepressants are commonly used in dementia. Depression is a frequent and
important co‐morbidity in dementia, and antidepressants are often used to treat depression …

Abstract Background Antidepressants (ADs) are commonly prescribed in primary care and
are mostly indicated for depression. According to the literature, they are now more frequently …

Antipsychotic treatments are associated with safety concerns in people with dementia. The
authors aimed to investigate whether risk of adverse outcomes related to antipsychotic …

Amyotrophic lateral sclerosis is a progressive and fatal neurodegenerative disease typically
presenting with bulbar or limb weakness. There is increasing evidence that amyotrophic …

Vascular dementia (VaD) is a common dementing illness. There are no pharmacological
agents with a regulatory approval for its treatment or prevention. Review of published clinical …

Summary BPSD (Behavioral and Psychological Symptoms in Dementia) affects virtually all
patients with dementia. The aim of this review is to present information on epidemiology …

Background: Until now, multiple reviews on the pharmacological treatment of dementia have
been published. Methods: We performed a scoping review to summarize research findings …

Abstract Purpose of Review To provide a comprehensive overview on the evaluation and
management of behavioral and psychological symptoms of dementia (BPSD) using …